BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36865008)

  • 1. PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations.
    Casal Moura M; Crowson CS; Specks U; Warrington KJ; Zand L; Sethi S; Fervenza FC
    Clin Kidney J; 2023 Mar; 16(3):432-436. PubMed ID: 36865008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis With Severe Kidney Disease.
    Casal Moura M; Zubidat D; Liebana MP; Sethi S; Soler MJ; Zand L; Dos Santos FG; Nardelli L; Leon-Roman J; Sousa C; Warrington KJ; Specks U; Fervenza FC
    Kidney Int Rep; 2024 May; 9(5):1284-1297. PubMed ID: 38707835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline.
    Zeng L; Walsh M; Guyatt GH; Siemieniuk RAC; Collister D; Booth M; Brown P; Farrar L; Farrar M; Firth T; Fussner LA; Kilian K; Little MA; Mavrakanas TA; Mustafa RA; Piram M; Stamp LK; Xiao Y; Lytvyn L; Agoritsas T; Vandvik PO; Mahr A
    BMJ; 2022 Feb; 376():e064597. PubMed ID: 35217581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea.
    Choi SE; Lee SB; Pyo JY; Ahn SS; Song JJ; Park YB; Lim BJ; Lee SW
    Sci Rep; 2023 Sep; 13(1):14850. PubMed ID: 37684336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.
    Boud'hors C; Riou J; Fage N; Samoreau C; Desouche A; Gatault P; Bridoux F; Martin C; Wacrenier S; Vinatier E; Djema A; Henry N; Croué A; Piccoli GB; Copin MC; Augusto JF; Brilland B;
    Clin Kidney J; 2023 Dec; 16(12):2530-2541. PubMed ID: 38046032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophilic cytoplasmic antibody-associated vasculitis and the kidney.
    Balani S; Kizilbash SJ; Kouri AM
    Curr Opin Pediatr; 2022 Apr; 34(2):197-202. PubMed ID: 34923562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
    Toyoda T; Yates M; Watts RA
    Curr Rheumatol Rep; 2022 Apr; 24(4):111-117. PubMed ID: 35316496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis.
    Bellos I; Michelakis I; Nikolopoulos D
    Clin Rheumatol; 2021 Apr; 40(4):1447-1456. PubMed ID: 32935248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
    Nezam D; Porcher R; Grolleau F; Morel P; Titeca-Beauport D; Faguer S; Karras A; Solignac J; Jourde-Chiche N; Maurier F; Sakhi H; El Karoui K; Mesbah R; Carron PL; Audard V; Ducloux D; Paule R; Augusto JF; Aniort J; Tiple A; Rafat C; Beaudreuil S; Puéchal X; Gobert P; Massy Z; Hanrotel C; Bally S; Martis N; Durel CA; Desbuissons G; Godmer P; Hummel A; Perrin F; Néel A; De Moreuil C; Goulenok T; Guerrot D; Grange S; Foucher A; Deroux A; Cordonnier C; Guilbeau-Frugier C; Modesto-Segonds A; Nochy D; Daniel L; Moktefi A; Rabant M; Guillevin L; Régent A; Terrier B;
    J Am Soc Nephrol; 2022 Mar; 33(3):628-637. PubMed ID: 35074934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
    Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
    Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic effect of plasma exchange on ANCA-associated vasculitis: A meta-analysis.
    Zhu Y; Rao J; Liu L; Ou J; Li W; Xue C
    Clin Nephrol; 2021 Jun; 95(6):312-322. PubMed ID: 33749583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
    Park PG; Yoo BW; Song JJ; Park YB; Lee SW
    BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.